Optimizing the patient care pathway through data-driven insights The patient’s journey in a healthcare setting is influenced by factors beyond the mere medical aspects of the case. Local […] February 20, 2024 · Janssen Pharmaceutica
From successful conception to a healthy family – Belgian research raises the bar for IVF Belgium is one of the top countries in the world for in vitro fertilization (IVF). Despite the high cumulative success […] March 27, 2024 · BioVox
Fraud in scientific institutes: a crack in the fabric of science The pursuit of scientific knowledge is at the heart of human progress – it leads to ground-breaking discoveries that have […] March 26, 2024 · V-Bio Ventures
Smart cities as living laboratories: a data-driven strategy for creating a sustainable future Similar to the growing use of large-scale scientific data to guide laboratory research, urban data presents significant potential for informed […] January 19, 2024 · BioVox
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive form of brain cancer. Behind […] January 22, 2024 · Press Release
V-Bio Ventures portfolio company Protealis secures EUR 22 million in oversubscribed B round funding to propel sustainable plant protein seed solutions Ghent, 23 January 2024 – Protealis, a leading innovator in seed solutions for sustainable plant proteins based in Ghent, Belgium, […] January 23, 2024 · V-Bio Ventures
Fund+ Portfolio Company Tubulis Closes Upsized EUR 128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline Financing round co-led by EQT Life Sciences and Nextech Invest1, with participation from current and new leading global biotechnology investors […] March 14, 2024 · Press Release
Azalea Vision Secures Prestigious European Innovation Council (EIC) Transition Grant Innovative Smart Contact Lens Developer Awarded €2.5M in Funding for Groundbreaking Ocular Health Technology Ghent, Belgium, March 12th, 2024 – […] March 12, 2024 · Press Release
Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care Leuven, Belgium, 21 November 2023 – ATHENA, a VLAIO-funded multi-stakeholder project, clears the path for increased reuse of Real-World Data […] November 21, 2023 · Press Release
Belgium needs boldness for healthcare innovation This year, Science for health will explore the inspiring innovations at the interface of biology and technology. The event will […] September 27, 2023 · Janssen Pharmaceutica
Lean years for company creation in Europe? After an exceptional sequence of socio-economic shocks over the past few years, the number of new companies being formed in […] September 27, 2023 · V-Bio Ventures
V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis Biosciences, a privately held life sciences company with an integrated […] September 20, 2023 · V-Bio Ventures
V-Bio Ventures portfolio company Corteria Pharmaceuticals raises EUR 65 million to advance its transformational medicines for cardiovascular diseases Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio company, is a biopharmaceutical company specialized in the […] September 7, 2023 · V-Bio Ventures
Biodevice-CRO: smart solutions for better bioprocessing Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership […] August 23, 2023 · MEDVIA